Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WRAIR Dengue Vaccine Phase II
NCT00350337Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Apr 2006
- Primary completion
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of T-DEN vaccine in dengue fever (4 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Neutralizing Antibody Geometric Mean Titer to Dengue Serotypes 1, 2, 3 and 4, Percentage of Subjects Seropositive for Dengue Serotypes 1, 2, 3 and 4 and 1 more. Started Apr 2006; status: completed.
02
Drugs
T-DEN vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT00350337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350337.